v3.26.1
Stockholders’ Equity (Deficit) (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Grant Date Fair Value of Stock Options Issued

The significant inputs utilized to determine the grant date fair value of stock options issued during the six month periods ended June 30, 2026, and 2025 were as follows:

 

   June 30,   June 30, 
   2026   2025 
Dividend Yield   0%   0%
Weighted average expected term (years)   6.25    5.38 
Volatility   173-179%   101.98%
Risk-free rate   4.31-4.46%   4.18%
Weighted average exercise price  $0.28   $0.97 
Schedule of Stock Option Activity

A summary of activity for the six months ended June 30, 2026, after giving effect to the Reverse Stock Split, is presented below:

 

   Number of
Options		   Weighted
Average
Exercise Price		   Weighted
Average
Contractual
Term (Years)		   Aggregate
Intrinsic
Value		 
Outstanding as of December 31, 2025   156,331   $77.56    5.4   $1,772,167 
Granted   56,502    21.19           
Exercised   (9,000)   0.61           
Forfeited   -    -           
Outstanding as of June 30, 2026   203,833    65.33    6.6    - 
Exercisable as of June 30, 2026   138,395    81.50    5.0    - 
Schedule of Employee Stock Options Outstanding

The following table summarized information about employee stock options outstanding as of June 30, 2026:

 

    Outstanding Options   Vested Options 
Exercise Price   Number Outstanding at June 30, 2026    Weighted Average Remaining Life   Number Exercisable at June 30, 2026   Weighted Average Remaining Life 
$20.85    46,684    9.94    -    - 
$21.00    7,152    10.00    -    - 
$27.65    2,666    9.76    832    9.76 
$55.47    22,099    2.57    22,099    2.57 
$60.00    37,109    2.80    37,109    2.80 
$72.75    3,333    8.92    2,137    8.92 
$89.25    4,765    9.01    -    - 
$92.25    6,461    9.19    2,654    9.19 
$100.00    72,814    6.58    72,814    6.58 
$162.00    750    4.96    750    4.96 
      203,833    6.56    138,395    5.02